Trebananib Active Not Recruiting Phase 2 Trials for Fallopian Tube Cancer / Cancer of the Ovary / Primary Peritoneal Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00479817Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer